Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0097 Transporter Info
Gene Name	SLC14A2
Transporter Name	Urea transporter 2
Gene ID	8170
UniProt ID	Q15849

Post-Translational Modification of This DT
Overview of SLC14A2 Modification Sites with Functional and Structural Information
Sequence	M S D P H S S P L L P E P L S S R Y K L Y E A E F T S P S W P S T S P D T H P A L P L L E M P E E K D L R S S N E D S H I V K I E K L N E R S K R K D D G V A H R D S A G Q R C I C L S K A V G Y L T G D M K E Y R I W L K D K H L A L Q F I D W V L R G T A Q V M F I N N P L S G L I I F I G L L I Q N P W W T I T G G L G T V V S T L T A L A L G Q D R S A I A S G L H G Y N G M L V G L L M A V F S E K L D Y Y W W L L F P V T F T A M S C P V L S S A L N S I F S K W D L P V F T L P F N I A V T L Y L A A T G H Y N L F F P T T L V E P V S S V P N I T W T E M E M P L L L Q A I P V G V G Q V Y G C D N P W T G G V F L V A L F I S S P L I C L H A A I G S I V G L L A A L S V A T P F E T I Y T G L W S Y N C V L S C I A I G G M F Y A L T W Q T H L L A L I C A L F C A Y M E A A I S N I M S V V G V P P G T W A F C L A T I I F L L L T T N N P A I F R L P L S K V T Y P E A N R I Y Y L T V K S G E E E K A P S G G G G E H P P T A G P K V E E G S E A V L S K H R S V F H I E W S S I R R R S K V F G K G E H Q E R Q N K D P F P Y R Y R K P T V E L L D L D T M E E S S E I K V E T N I S K T S W I R S S M A A S G K R V S K A L S Y I T G E M K E C G E G L K D K S P V F Q F F D W V L R G T S Q V M F V N N P L S G I L I I L G L F I Q N P W W A I S G C L G T I M S T L T A L I L S Q D K S A I A A G F H G Y N G V L V G L L M A V F S D K G D Y Y W W L L L P V I I M S M S C P I L S S A L G T I F S K W D L P V F T L P F N I T V T L Y L A A T G H Y N L F F P T T L L Q P A S A M P N I T W S E V Q V P L L L R A I P V G I G Q V Y G C D N P W T G G I F L I A L F I S S P L I C L H A A I G S T M G M L A A L T I A T P F D S I Y F G L C G F N S T L A C I A I G G M F Y V I T W Q T H L L A I A C A L F A A Y L G A A L A N M L S V F G L P P C T W P F C L S A L T F L L L T T N N P A I Y K L P L S K V T Y P E A N R I Y Y L S Q E R N R R A S I I T K Y Q A Y D V S
PTM type	X-N-glycosylation X-Phosphorylation X: Amino Acid

N-glycosylation
Asparagine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC14A2			[1]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	271
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC14A2 Asparagine 271 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC14A2			[2]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	733
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC14A2 Asparagine 733 has the potential to affect its expression or activity.
Phosphorylation
Serine	8 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC14A2			[3]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	6
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC14A2 Serine 6 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC14A2			[3]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	7
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC14A2 Serine 7 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC14A2			[4]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	32
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC14A2 Serine 32 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC14A2			[5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	92
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC14A2 Serine 92 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC14A2			[5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	229
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC14A2 Serine 229 has the potential to affect its expression or activity.
PTM Phenomenon 6	Have the potential to influence SLC14A2			[6]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	558
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC14A2 Serine 558 has the potential to affect its expression or activity.
PTM Phenomenon 7	Have the potential to influence SLC14A2			[5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	691
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC14A2 Serine 691 has the potential to affect its expression or activity.
PTM Phenomenon 8	Have the potential to influence SLC14A2			[7] , [8]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	901
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC14A2 Serine 901 has the potential to affect its expression or activity.
Threonine	2 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC14A2			[4]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	33
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC14A2 Threonine 33 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC14A2			[6] , [9]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	561
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC14A2 Threonine 561 has the potential to affect its expression or activity.
Tyrosine	5 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC14A2			[4]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	18
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC14A2 Tyrosine 18 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC14A2			[4]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	511
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC14A2 Tyrosine 511 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC14A2			[6]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	559
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC14A2 Tyrosine 559 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC14A2			[7] , [8]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	898
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC14A2 Tyrosine 898 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC14A2			[7] , [8]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	899
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC14A2 Tyrosine 899 has the potential to affect its expression or activity.

References
1	97- and 117-kDa forms of collecting duct urea transporter UT-A1 are due to different states of glycosylation. Am J Physiol Renal Physiol. 2001 Jul;281(1):F133-43.
2	dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: UT2_HUMAN)
3	Proteogenomics connects somatic mutations to signalling in breast cancer. Nature. 2016 Jun 2;534(7605):55-62.
4	Improve the coverage for the analysis of phosphoproteome of HeLa cells by a tandem digestion approach. J Proteome Res. 2012 May 4;11(5):2828-37.
5	Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
6	Citric acid-assisted two-step enrichment with TiO2 enhances the separation of multi- and monophosphorylated peptides and increases phosphoprotein profiling. J Proteome Res. 2013 Jun 7;12(6):2467-76.
7	A Methodological Assessment and Characterization of Genetically-Driven Variation in Three Human Phosphoproteomes. Sci Rep. 2018 Aug 14;8(1):12106.
8	Radio-sensitizing effects of VE-821 and beyond: Distinct phosphoproteomic and metabolomic changes after ATR inhibition in irradiated MOLT-4 cells. PLoS One. 2018 Jul 12;13(7):e0199349.
9	Kinase activity ranking using phosphoproteomics data (KARP) quantifies the contribution of protein kinases to the regulation of cell viability. Mol Cell Proteomics. 2017 Sep;16(9):1694-1704.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence